<div class="headers"><div>Figure 2. Population with a body mass index Z25 kg/m2: differences (odds ratios with 95% CIs) at 52 weeks between the canagliï¬‚ozin 100-mg and 300-mg groups and sitagliptin.HbA1c = glycosylated hemoglobin; BP = blood pressure.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; text-align: left;'></td>
<td style='border-top: 2px solid grey; text-align: left;'><p style="font-weight: bold; " class="bold ">Canagliflozin 100 mg vs Sitagliptin 100 mg</p></td>
<td style='border-top: 2px solid grey; text-align: left;'><p style="font-weight: bold; " class="bold ">Canagliflozin 300 mg vs Sitagliptin 100 mg</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">HbA1c < 7.0%, BP < 130/80 mm Hg, LDL-C < 100 mg /dL</p></td>
<td style='text-align: left;'><p style="" class="">1.71</p></td>
<td style='text-align: left;'><p style="" class="">1.94</p></td>
</tr>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">HbA1c < 8.0%, BP < 140/90 mm Hg, LDL-C < 100 mg /dL</p></td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">1.35</p></td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">1.57</p></td>
</tr>
</tbody>
</table>
